Click Here |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: June 2023
Volume 8 | Issue 6
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 8
Issue Published : 85
Article Submitted : 7835
Article Published : 4002
Total Authors : 10443
Total Reviewer : 547
Total Countries : 81
Indexing Partner
Licence
Published Paper Details
|
|
Paper Title: | FORMULATION AND EVALUATION OF FAST DISSOLUTION TABLET OF DOXAZOSIN MESYLATE |
Authors Name: | Rewati Raman , Sandeep sahu , Ritesh jain , Suruchi prasad , Satish sahu |
Download E-Certificate: | Download |
Author Reg. ID: |
IJRTI_183410
|
Published Paper Id: | IJRTI2208023 |
Published In: | Volume 7 Issue 8, August-2022 |
DOI: | |
Abstract: | Tablet is the most widely used dosage form because of its convenience in terms of self-administration, compactness and ease in manufacturing. Patients often experience difficulty in swallowing conventional tablets when water is not available nearby. According to European pharmacopeia, these MDTs should dissolve in less than three minutes. The formulation is more useful for the bed ridden and patients who have the swallowing problem. Solid dispersion is one of the accepted approaches for dissolution enhancement. They are molecular mixtures of poor water-soluble drugs with hydrophilic carriers prepared by solvent evaporation and melting method. Doxazosin mesylate (DM), a quinazoline derivative, could be used in the treatment of mild to moderate hypertension and also in the management of symptomatic benign prostatic hyperplasia (BPH). In hypertensive patients, DM reduces the blood pressure by selective antagonizing the postsynaptic alpha1 adrenergic receptors |
Keywords: | mouth dissolving tablet, solid dispersion, doxazosin. |
Cite Article: | "FORMULATION AND EVALUATION OF FAST DISSOLUTION TABLET OF DOXAZOSIN MESYLATE", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 8, page no.129 - 135, August-2022, Available :http://www.ijrti.org/papers/IJRTI2208023.pdf |
Downloads: | 000202411 |
ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
Publication Details: |
Published Paper ID: IJRTI2208023
Registration ID:183410
Published In: Volume 7 Issue 8, August-2022
DOI (Digital Object Identifier):
Page No: 129 - 135 Country: Bilaspur, Chattisgarh, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2208023 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2208023 |
Share Article: | |
Click Here to Download This Article |
|
Article Preview | |
|
Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
![]() |
![]() |
![]() |
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
![]() Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
Important Details
Social Media
Indexing Partner |
|||
Copyright © 2023 - All Rights Reserved - IJRTI |
Facebook Twitter Instagram LinkedIn